Clinical Trials Directory

Trials / Completed

CompletedNCT03722615

Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
University of Witwatersrand, South Africa · Academic / Other
Sex
All
Age
1 Minute – 48 Hours
Healthy volunteers
Accepted

Summary

The aim of this project is to determine the epidemiology of congenital cytomegalovirus (CMV) infection and incidence of subsequent permanent neurological sequelae in a high HIV prevalent setting in Soweto, Johannesburg. A cross-sectional study will be conducted on mother-infant pairs, screening mothers for CMV infection and newborns for congenital CMV infection. Maternal CMV prevalence will be determined by testing for CMV specific antibodies in blood. Newborn congenital infection will be determined by polymerase chain reaction (PCR) tests on newborn saliva and urine within 3 weeks of birth. Various risk factors associated with congenital CMV such as HIV exposure, and gestational age will be assessed. The association between maternal vaginal CMV shedding postnatally with congenital CMV infection will be explored by swabbing maternal vaginal fluid and conducting quantitative CMV PCR analysis. Newborns confirmed with congenital CMV and a control group of uninfected newborns will form a cohort to be followed up until 12 months of age monitoring for various neurological sequelae such as hearing loss, neurodevelopmental impairment, ocular damage, cerebral damage and seizures. A comparison of vaccine immune responses between cases of congenital CMV and the CMV uninfected infants to the primary series of vaccines in the National Expanded Programme on Immunisation will be compared. The contribution of CMV infection to neonatal death and stillbirths will be described by minimally invasive tissue sampling (MITS) for CMV on babies that die during the neonatal period and stillbirths.

Conditions

Timeline

Start date
2016-05-06
Primary completion
2019-04-01
Completion
2019-04-01
First posted
2018-10-29
Last updated
2019-08-06

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT03722615. Inclusion in this directory is not an endorsement.